Earnings Call · Q2 FY2024·2024-08-01

Q2 24EPS +0.60%·Rev n/aQ1 24EPS +14.01%·Rev n/aQ4 23EPS +100.00%*·Rev n/aQ3 23EPS -100.00%*·Rev n/a⚠ consensus missing

Moderna, Inc. MRNA

Lavina Talukdar — Head of Investor Relations

Stéphane Bancel — Chief Executive Officer

Jamey Mock — Chief Financial Officer

Stephen Hoge — President

−21.0%1d on move date−19.6% vs SPY3d−29.8%5d−31.6%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRNA calls or request research access.

More MRNA calls Browse calls Request research access